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from our research group have indicated that trans-
plantation of freshly cultured fetal rat cardiomyo-
cytes2 and autologous heart cells3 into myocardial
scar tissue limited scar expansion and improved car-
diac function. 
Myocyte implantation into myocardial tissue is thesubject of increasing attention. In experimental
models of left ventricular cryonecrosis, skeletal mus-
cle myoblast transplantation has been demonstrated
to improve myocardial function.1 In addition, results
Background: The present study examined the survival and rate of contraction
of (1) cardiomyocytes cultured from cryopreserved fetal rat myocardium and
(2) cryopreserved cultured cardiomyocytes. In addition, the effects of trans-
plantation of cryopreserved fetal cardiomyocytes were evaluated.
Methods: Segments of fetal rat myocardial tissue (0.2, 2.0, and 6.0 mm3
mince size) and cultured cardiomyocytes were cryopreserved in liquid nitro-
gen for 1, 2, and 4 weeks. After cryopreservation, the tissue samples and cul-
tured cardiomyocytes were thawed at 37°C and cultured, and cell prolifera-
tion and rate of contraction were determined. Cultured cryopreserved (n = 5)
and noncryopreserved (control, n = 5) fetal cardiomyocytes were transplant-
ed into the subcutaneous tissue and into a transmural left ventricular free
wall scar of Sprague-Dawley rats (n = 3). The survival and rate of contrac-
tion of these transplanted cells were also examined. 
Results: Cryopreservation of cultured fetal cardiomyocytes resulted in viable
and functional cardiomyocytes although the cell number and percentage of
beating cells were diminished. Survival of cardiomyocytes isolated from
cryopreserved fetal myocardium was a function of tissue size before cryo-
preservation; the lowest survival was recorded in tissues with the largest
mince size (6.0 mm3). The subcutaneous transplants contracted sponta-
neously and regularly with an idioventricular rhythm. In addition, the trans-
planted cardiomyocytes were elongated and formed a myocardium-like pat-
tern with blood vessels present within the contractile tissue. In the
transmural left ventricular scar, both control and experimental fetal car-
diomyocyte transplants formed myocardium-like tissue. 
Conclusions: The present study uncovers the following key observations: (1)
cryopreservation of fetal cardiomyocytes and cardiomyocytes isolated from
cryopreserved myocardial tissue results in viable and functional cells, (2)
cryopreserved fetal cardiomyocytes can be successfully transplanted into
subcutaneous and myocardial scar tissue, and (3) improvements in cryo-
preservation techniques are required to augment the rates of cardiomyocyte
survival observed in the study. (J Thorac Cardiovasc Surg 2001;121:98-107)
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Cryopreservation represents an important and viable
means of long-term storage of tissues and cells and has
been widely used clinically. Cardiomyocyte cryopreser-
vation, although previously not studied, represents a
provocative area of research, which may serve to uncov-
er novel means of restoring cardiac function in patients
requiring a second transplantation of cells. In this study
we describe, for the first time, the survival and contrac-
tile function of cryopreserved cardiomyocytes cultured
from fetal rat myocardial tissue. In addition, we demon-
strate the successful transplantation of cryopreserved
cardiomyocytes into the subcutaneous tissue and
myocardial scar tissue of Sprague-Dawley rats. 
Material and methods
Animals. All procedures and protocols were approved by the
Animal Care Committee of the University Health Network
(Toronto, Ontario, Canada). Sprague-Dawley rats (Charles
River Canada Inc, St Constant, Quebec, Canada) were used in
the study. Fetal rat cardiomyocytes were freshly isolated from
18- to 20-day gestational age rat hearts. All experiments were
performed in accordance with the “Guide for the Care and Use
of Laboratory Animals” published by the National Academy
Press, revised 1996).
Cell preparation. Fetal rat cardiomyocytes (18- to 20-day
gestational age) were isolated by means of an enzymatic
digestion method and cultured. In brief, pregnant rats were
anesthetized with ketamine (22 mg/kg body weight, intra-
muscularly) and pentobarbital (30 mg/kg body weight,
intraperitoneally). Fetal rat hearts were excised and then
washed with phosphate-buffered saline (PBS) solution. After
removal of all connective tissue, blood vessels, and the atria,
the ventricles were minced and incubated in a PBS solution
containing trypsin (0.2%), collagenase (0.1%), and glucose
(0.02%) for 30 minutes at 37°C. The cardiac cells were then
isolated by repetitive pipetting of digested myocardial tissue.
The cells in the supernatant were transferred into a tube con-
taining 15 mL of cell culture medium. The tube was cen-
trifuged at 600g for 5 minutes at room temperature. 
Cell culture studies. The cell pellet was resuspended in
culture medium. The cardiomyocytes were purified by a pre-
plating method,4 which takes advantage of the finding that
Fig 1. A, The effects of 1, 2, and 4 weeks of cryopreservation on cell number 10 days after thawing. The control
group represents the noncryopreserved cells. Results are presented as mean ± SE (*P = .004, control different from
1-, 2-, and 4-week values). B, The effects of 1, 2, and 4 weeks of cryopreservation on the percentage of beating
cells 10 days after thawing. The control group represents the noncryopreserved cells. Results are presented as mean
± SE (*P = .01, control different from 1-, 2-, and 4-week values). 
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cardiomyocytes require a longer time to attach to a cell cul-
ture dish than other cells in the myocardium (such as fibro-
blasts). The freshly isolated myocardial cells were plated on
dishes and cultured for 2 hours at 37°C. The supernatant con-
taining the suspended cells was transferred into another dish
for further culturing. The cardiomyocytes were cultured at
37°C in 5% carbon dioxide and 95% air as described earlier.2
For cryopreservation, fetal cardiomyocytes were transferred
to cryogenic vials (2.0 mL Nalgene cryovials; Applied
Scientific, South San Francisco, Calif). They were resus-
pended in 2.0 mL of freezing medium (70% Iscove’s modi-
fied Dulbecco’s medium and 20% fetal bovine serum) and
10% dimethylsulfoxide (DMSO). The vials were placed into
Nalgene cryovial freezing containers and cooled at a rate of
–1°C per minute until a temperature of –80°C was reached
(approximately 4 hours). The cryovials were then stored in
liquid nitrogen. Control cells were not cryopreserved. After 1,
2, and 4 weeks the cryopreserved samples were rapidly
thawed in a 37°C water bath. Freezing medium was removed
by dilution with culture medium after centrifugation for 5
minutes in 4 steps (10%, 5%, 2.5%, and 0% DMSO) (approx-
imately 30 minutes).
Tissue preservation. Cardiac tissues were separated into 3
groups on the basis of the minced size before cryopreserva-
tion. Groups 1, 2, and 3 were minced to less than 0.2 mm3,
2.0 mm3, and 6.0 mm3, respectively. The tissues were then
cryopreserved by means of the method described above and
stored in liquid nitrogen for 1 week. After cryopreservation,
the tissues were thawed and the cells were isolated and cul-
tured as described above.
Cultured cell evaluation 
Proliferation. The proliferation of cryopreserved and non-
cryopreserved cells was determined by cell growth curves.
The number of cells was determined daily for 10 days begin-
ning on day 1 after thawing.
Rate of contraction. The rate of contraction, percentage
of regular beating cells, and percentage of irregularly beat-
ing cells were examined for 10 days after thawing. The
beating cardiomyocytes were observed in a 37°C heated
chamber with a Nikon microscope (Nikon Corporation,
Tokyo, Japan). The percentage of beating cells was deter-
mined by counting the number of beating cells (both regu-
larly or irregularly beating cells) and the total number of
cells in 5 random fields. 
Fig 1. Cont’d. C, The effects of 1, 2, and 4 weeks of cryopreservation on the beating rate 10 days after thawing.
The control group represents the noncryopreserved cells. Results are presented as mean ± SE (P > .05, no differ-
ence between groups). D, The effects of 1, 2, and 4 weeks of cryopreservation on the percentage of irregularly beat-
ing cells 10 days after thawing. The control group represents the noncryopreserved cells. Results are presented as
mean ± SE (P > .05, no difference between groups). 
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Transplantation studies. Cardiac cells were cryopreserved,
thawed, and cultured as described above. The cultured cells
were dissociated from the culture dishes with the trypsin solu-
tion and collected by centrifugation at 600g for 5 minutes at
room temperature. Once the cell number was determined, 4.2
± 0.9 × 106 cells were resuspended in 1.0 mL of saline solution.
A 0.25-mL portion of the cell suspension was used for the sub-
cutaneous implantation and 2.5 × 106 (suspended in 0.08 mL)
for the myocardial scar transplantation experiment.
Identification of transplanted cells in the myocardial
scar. To identify the transplanted cells in the scar tissue, we
labeled the cells with bromo-deoxyuridine (BrdU) (Sigma
Chemical Company, St Louis, Mo)5 before transplanting
them. In brief, 10 µL of BrdU solution (BrdU 50 mg, DMSO
0.8 mL, and water 1.2 mL) was added into each culture dish
1 day before the transplantation and incubated with the cells
for 24 hours. Labeling efficiency was approximately 90%.
The labeled cells were transplanted into the 4-week-old trans-
mural left ventricular scar,2 and samples were collected after
4 weeks of transplantation. Monoclonal antibodies against
BrdU were used to localize the transplanted cardiomyocytes.
After the paraffin had been removed with toluene, the sam-
ples were serially rehydrated with 100%, 95%, and 70%
ethanol. Endogenous peroxidase in the samples was blocked
with 3% H2O2 for 10 minutes (room temperature). The sam-
ples were treated with pepsin for 5 minutes at 42°C and 2N
HCl for 30 minutes (room temperature). After 3 rinses with
PBS solution, the samples were incubated with antibodies
against BrdU in a moist chamber for 16 hours (room temper-
ature). A negative control sample was incubated in PBS solu-
tion (without the primary antibodies) under the same condi-
tions. The test and control samples were rinsed with PBS
solution 3 times (15 minutes each) and then incubated with
goat anti-rabbit immunoglobulin G conjugated with peroxi-
dase (37°C for 45 minutes). The samples were washed 3
times (15 minutes each) with PBS solution and then
immersed in diaminobenzidine H2O2 solution (2 mg/mL
diaminobenzidine and 0.03% H2O2 in 0.03 mL/L phosphate
buffer) for 15 minutes. After being washed with PBS solu-
tion, the samples were coverslipped and photographed.
Cell transplantation
Subcutaneous transplantation. All procedures were per-
formed with the animals under general anesthesia (keta-
mine, 22 mg/kg body weight intramuscularly, and pento-
barbital, 30 mg/kg body weight intraperitoneally). Once
the animals were anesthetized, the superficial subcutaneous
tissue of the quadriceps muscle was exposed through a 20-
mm skin incision, and the cell suspension of cryopreserved
fetal cardiomyocytes (n = 5 rats) was injected with a tuber-
culin syringe (see Fig 3, A). The skin incision was closed
with 3-0 silk. The contralateral leg was injected with non-
cryopreserved cardiomyocytes (n = 5) and served as the
control. The rats were housed in cages fitted with a filter
and received cyclosporine A (INN: ciclosporin) at a dose of
5 mg/kg body weight per day (subcutaneously). Benzathine
penicillin G, 37,500 U, and procaine penicillin G, 37,500
U, were administered intramuscularly every 3 days to each
rat for 1 week after the operation. Buprenorphine HCl
(0.01-0.05 mg/kg body weight) was given subcutaneously
every 8 to 12 hours for the first 2 days after the operation
to provide analgesia. On day 28 after transplantation, the
animals were anesthetized, the transplanted area was
exposed, and contractile function of the transplanted cells
was recorded. The electrical activity of the transplanted
cells was recorded with electrocardiography (Patient Care
Management System, model 90303B; Spacelabs Medical,
Fig 2. Effects of cryopreservation of fetal rat myocardial tissue on the percentage of cultured beating cardiomy-
ocytes. Fetal rat myocardial tissue was minced to 3 sizes before cryopreservation (0.2 mm3, 2.0 mm3, and 6.0 mm3)
and cryopreserved for 1 week. After cryopreservation, cultured cardiomyocytes were isolated and cultured and the
percentage of beating cells recorded in the 3 groups. Data are expressed as mean ± SE. #P = .008, different from
groups 2 and 3. @P = .005, different from groups 1 and 2. *P = .005, different from group 3. 
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Inc, Redmond, Wash) by placing a probe at each end of the
transplanted tissue. The transplanted tissue was then col-
lected for histologic studies. 
Myocardial transplantation. In brief, the rats were anes-
thetized with ketamine followed by pentobarbital as
described above. The anesthetized rats were intubated with a
14-gauge catheter and positive-pressure ventilation was
maintained (3 mL/ventilation, 60 ventilations/min, room air
supplemented with oxygen [flow rate 6 L/min]) using a
Harvard ventilator (model 683; Harvard Apparatus Co, South
Natick, Mass). The myocardium (n = 5) was exposed through
a 2-cm left lateral thoracotomy. The left ventricular free wall
was then frozen with a 0.8 × 1.2-cm liquid nitrogen probe (15
applications of 20 seconds’ duration each). The muscle layer
and skin were closed with 5-0 sutures. The rats were moni-
tored for 4 hours postoperatively. Benzathine penicillin G,
37,500 U (intramuscularly), and procaine penicillin G,
37,500 U (intramuscularly), were given to each rat every 3
days for 1 week after the operation. In addition, buprenor-
phine (0.01-0.05 mg/kg body weight) was administrated sub-
cutaneously every 8 to 12 hours for the first 48 hours after the
operation for analgesia. 
Four weeks after cryoinjury, the rat heart was exposed
through a midline sternotomy with the rat under general anes-
thesia.2 The myocardial scar was exposed through a midline
sternotomy. An 80-µL aliquot of cardiomyocyte suspension
Fig 3. A, Fetal cardiomyocyte suspension being injected into the subcutaneous tissue of an adult rat hind limb. B,
Contractile cardiomyocyte transplant (A) 4 weeks after the implantation. Successful transplantation into the sub-
cutaneous tissue is depicted (dimensions: 14 × 4 mm2).
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containing 2.5 × 106 cells was injected by means of a tuber-
culin syringe into the center of the left ventricular free wall
scar tissue of each animal (n = 3) in the transplant group. An
80-µL aliquot of Iscove’s modified Dulbecco’s medium was
injected into the center of the scar tissue of the control hearts
(n = 3). Cell and medium leakage from the site of injection
was prevented by the application of cryoprecipitate. The chest
was closed with 3-0 silk sutures. Antibiotics and analgesics
were given as described above.
Histology. After 4 weeks of transplantation, subcutaneous
and myocardial tissues were collected and fixed in 5% glacial
acetic acid (in methanol) for histologic studies (n = 6 sam-
ples). The samples were embedded and sectioned to yield 10-
µm thick slices and stained with hematoxylin and eosin.
Statistical analysis. Results are presented as mean ± SE.
Statistical analysis was performed by repeated-measures analy-
sis of variance with the use of the Number Cruncher Statistical
System (NCSS Statistical Software, Kaysville, Utah) followed
by a Newman-Keuls test for post hoc comparisons.
Results
Proliferation and rate of contraction of cultured
fetal cardiomyocytes after cryopreservation. Fig 1, A
and B, depicts the effects of cryopreservation of cul-
tured fetal cardiomyocytes on cell number and percent-
age of beating cells at day 10 after thawing.
Cryopreservation of fetal rat cardiomyocytes (for 1, 2,
or 4 weeks) resulted in lower cell numbers when com-
pared with the noncryopreserved control group (Fig 1,
A, *P = .004 different from 1-, 2-, and 4-week values).
In addition, the percentage of beating cells was also
diminished after 1, 2, and 4 weeks of cryopreservation
(Fig 1, B, *P = .01 different from 1-, 2-, and 4-week
values). In contrast, the beating rates and percentage of
irregularly beating cells were not affected by cryo-
preservation of fetal cardiomyocytes (Fig 1, C and D,
P > .05). 
Contractility of cardiomyocytes isolated from
cryopreserved fetal myocardium. The contractile
function of cardiomyocytes isolated from cryopre-
served fetal rat myocardial tissue is depicted in Fig 2.
As discussed earlier, segments of fetal rat myocardium
were minced into 3 sizes (0.2 mm3, 2.0 mm3, and 6.0
mm3) and cryopreserved for 1 week. After cryopreser-
vation, the tissues were thawed, the cells isolated and
cultured, and the percentage of beating cells was deter-
mined. The number of beating cells isolated in this
fashion was a function of the size of the tissue; the low-
est percentage of beating cells was recorded in the
group with the largest mince size (0.6 mm3) (Fig 2). In
contrast to the results obtained after cryopreservation
of cultured fetal cardiomyocytes, the percentage of
beating cells isolated from cryopreserved fetal myocar-
dial tissue was significantly lower (average of groups 1,
2, and 3 on day 6 [3% ± 2%] vs percentage of beating
cells following cryopreservation of cultured fetal car-
diomyocytes on day 6 [28% ± 3%], P = .0001). 
Transplantation experiments. Four weeks after
subcutaneous transplantation of cryopreserved car-
Fig 4. A, Electrocardiogram of the host rat heart. The heart rate was 219 beats/min. B, Electrical activity of the fetal
cardiomyocyte transplant formed in the subcutaneous tissue of the adult rat hind limb 4 weeks after transplantation
of cryopreserved fetal cardiomyocytes. The tissue beats at 60 beats/min with an idioventricular rhythm. 
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diomyocytes, a spontaneously contractile tissue of
approximately 0.5 cm3 in size was apparent in the 2
transplantation sites of each animal (Fig 3, B). Four of
5 animals in the experimental group (80%) and 3 of 5
animals in the control group (60%) underwent success-
ful transplantation. The experimental (n = 4) and con-
trol tissues (n = 3) beat spontaneously at rates of 60 ±
9 and 34 ± 2 beats/min with an idioventricular rhythm
(Fig 4, A and B). The transplanted cells were elongated
and formed myocardium-like tissue with blood vessels
Fig 5. Hematoxylin and eosin photomicrograph (100×) of fetal heart cell transplantation into the rat hind limb sub-
cutaneous tissue. A, The 4-week-old transplant formed from a cryopreserved cardiomyocyte suspension. B, The 4-
week-old transplant formed from a noncryopreserved cardiomyocyte suspension. Evidence of immunologic rejec-
tion is present. L, lymphocytes; TM, transplant muscle; M, host muscle.
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present within the contractile tissue (Fig 5). After trans-
plantation, BrdU-labeled myocardium-like tissue was
observed in the center of the left ventricular free wall
scar (Fig 6) only in the rats injected with fetal car-
diomyocytes. A diffuse inflammatory reaction was
present in the tissue (Fig 5). The tissue did not appear
to be in contact with the host myocardium. 
Discussion
Cryopreservation is a practical method for long-term
storage of tissues and cells and has been successfully
used in storing cardiac valves, blood vessels, and bone
marrow cells.6-8 The effects of cryopreservation on sur-
vival and function of cultured cardiomyocytes has not
been previously described. In this article, we address
Fig 6. Photomicrographs of a 4-week-old fetal cardiomyocyte transplant in adult rat myocardial scar tissue. A,
Arrows point to the transplant in the scar tissue of the left ventricular free wall. B, Hematoxylin and eosin stain of
the transmural scar with transplant infiltrated with lymphocytes indicative of immunorejection (40×). C, Some car-
diomyocytes labeled with BrdU were transplanted and identified in the transplant as indicated by the arrows
(400×). TM, Transplant muscle.
this issue and demonstrate for the first time that cryo-
preserved fetal cardiomyocytes are both viable and
functional and can be successfully transplanted into
subcutaneous and myocardial scar tissue.
With respect to the data presented in this article, a few
issues merit brief discussion. Fetal rat cardiomyocytes
retained myocardium-like characteristics in culture after
cryopreservation. With long storage times, the cell num-
bers and percentage of beating cells were diminished at
day 10 after thawing. In addition, cell passage decreased
the survival and rate of contraction to an equal degree in
both groups (not shown). These data raise an important
technical issue regarding the rate of survival of cultured
fetal cardiomyocytes after cryopreservation. Despite the
use of standard cryopreservation techniques, rapid thaw-
ing, and effective culture methodology, cryopreservation
of freshly prepared cardiomyocytes was associated with
high rates of cell loss. Clearly, improving and refining
cryopreservation techniques may be needed to augment
cardiomyocyte yield and function. 
Cryoprotectants have been demonstrated to affect
the secondary protein structure through changes in
water structure and/or by a direct interaction between
the cryoprotectant and the protein.9 Gottsauner-Wolf
and associates10 have previously demonstrated that
freezing and subsequent thawing significantly
decrease the tensile properties of normal skeletal
muscle. Furthermore, the method of removing
DMSO was an important determinant of cell survival,
with cell injury apparent when the DMSO was
removed by diluting it with culture medium at 37°C.
Studies of thermal expansion at varying concentra-
tions of DMSO may be useful in improving the cell
survival after cryopreservation.
The number of contractile cardiomyocytes isolated
from cryopreserved fetal myocardial tissue was a func-
tion of mince size before cryopreservation; the lowest
percentage of beating cells was obtained in the tissues
with the largest mince size (6.0 mm3 vs 0.2 mm3). This
may reflect a relative inability of DMSO to diffuse into
myocardial cells with larger tissue/mince size. In addi-
tion, the percentage of beating cardiomyocytes cultured
from cryopreserved fetal myocardial tissue was lower
than that observed after cryopreservation of freshly cul-
tured cardiomyocytes. Although we are unable to pro-
vide an explanation for this finding, it is plausible that
cryopreservation of myocardial tissue favored survival of
noncardiomyocyte cells and/or nonfunctional cardiomy-
ocytes after culture. Research efforts in this direction are
required to shed light on this issue. 
The present study also describes the successful trans-
plantation of cryopreserved fetal cardiomyocytes into
subcutaneous tissue and myocardial scar tissue of
Sprague-Dawley rats. In the subcutaneous tissue, spon-
taneously beating myocardium-like tissue was formed
4 weeks after the transplantation of cryopreserved fetal
cardiomyocytes. The beating rate of the myocardial
scar tissue transplant could not be ascertained because
of the background beating rate of the host myocardium.
Despite the use of cyclosporine, the subcutaneous and
myocardial transplants were infiltrated with lympho-
cytes, indicating the presence of various degrees of
immunorejection. 
Limitations and perspective 
We would like to briefly address some of the limi-
tations of the present study in an effort to encourage
future studies in this area. Our primary purpose was
to evaluate the viability and percentage of beating
cells of cryopreserved fetal cardiomyocytes and car-
diomyocytes isolated from cryopreserved fetal
myocardial tissues. There are significant differences
in fetal versus adult cardiomyocytes, which should be
kept in mind while interpreting the data. Since the
use of cyclosporine (in our study) makes the applica-
bility of homologous myocytes uncertain, studies
using genetically identical rats are needed to elimi-
nate this factor. 
In summary, freshly cultured fetal cryopreserved
cardiomyocytes and cardiomyocytes cultured from
cryopreserved fetal myocardial tissue are viable and
functional. Furthermore, transplantation of cryopre-
served fetal cardiomyocytes forms myocardium-like
tissue in the rat subcutaneous tissue and left ventric-
ular free wall scar. Further refinements of the cryo-
preservation techniques are needed to augment the
rates of cardiomyocyte survival and improve the per-
centage of beating cardiomyocytes reported in this
article.
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